HomeMarket NewsMicro Cap StocksImmunoPrecise Antibodies Takes a Financial Hit as They Announce Pricing of Public...

ImmunoPrecise Antibodies Takes a Financial Hit as They Announce Pricing of Public Offering

Actionable Trade Ideas

always free

stock 624712

  • ImmunoPrecise announced pricing of a $1.1 million public offering.
  • There’s also an option for underwriters to buy an additional 165,000 shares within 30 days.

ImmunoPrecise Antibodies LtdΒ IPA shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at $1.00 per share.

There’s an option for underwriters to buy an additional 165,000 shares within 30 days. The offering is set to close on December 8, provided it meets standard conditions.

ImmunoPrecise plans to utilize the funds for research and development, expanding lab facilitiesΒ and general corporate purposes.

See Also:Β Cooling Signs In US Job Market Raise Concerns Ahead of November Jobs Report

According to data fromΒ Benzinga Pro, IPA has a 52-week high of $5.90 and a 52-week low of $0.94.


Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.